About SynDevRx
Management

The SynDevRx executive team has many years of relevant experience in drug development, operations and establishing partnerships. We are disciplined, resourceful and focused on project execution.  We operate on a highly cash-efficient basis, strategically using top quality CROs and CMOs.

 

Key Management and Consultants

Bradley J Carver, co-Founder, President and CEO

Brad has a 17 year history as a senior manager in biotech. As President and CEO of GlycoGenesys (Russell 2000 and NASDAQ listed), Brad increased the company's market cap from $25M to well over $500M in less than 5 years.  He successfully completed development and research partnerships deal with institutions like Elan Pharmaceuticals and MIT,  Brad oversaw multiple clinical trials of one of the world's first complex carbohydrate cancer drug candidates GCS100, requiring novel manufacturing and analytic method development. Brad’s successful execution, resourcefulness and team building skills allowed the company to solve unique and complex manufacturing and characterization issues, identify and characterize multiple mechanisms of action for GCS-100. He led the clinical trial program design effort and was key in selecting the target indications.

Brad attended Michigan State University, where he received his BA in Business.

John Petersen, Ph.D., VP Research and Development

John is a Ph.D. in synthetic chemistry with over 20 years biotech experience. While a senior manager at GelTex, John was responsible for taking the polymeric drug Renagel® from concept through NDA in both US and European markets. John has the rare experience of taking a drug from pre-IND to approval.  He has unmatched expertise in polymeric drug development, product manufacturing, and project execution. John completed his undergraduate degree at MIT, and his Ph.D. at UC Berkeley under Dr. Rappaport.

James M. Shanahan, co-Founder, VP Business Development

Jim is a serial entrepreneur with over 12 years of successful experience in Business Development.  Previously, he was co-founder and VP Marketing at JAM Technologies, Inc., where he successfully completed licensing deals of the company's novel platform technology with AKM Japan, and was instrumental in forming strategic co-development partnerships with Intel and others.  Jim also built the company's sales and distribution channels throughout Asia, plus established the company's market positioning with industry leaders including Bose, Apple Computer, Dell, National Semiconductor, and SRS among others.  He also was responsible for establishing all initial sales opportunities with major OEMs in Japan, Taiwan, China and Korea.

Jim managed all aspects of the company's operations from inception to the Series B round, including financing, legal, licensing, IP, and strategic planning. Jim has one issued patent from his work at JAM. Jim attended the University of Massachusetts at Amherst with concentrations in engineering, math and language, and L'Universite Catholique, Angers France.

 

Watch here for upcoming announcements on additional key management.